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A B S T R A C T
In this case report, we describe the implant of a transvenous implantable cardioverter-deﬁbrillator lead
on the left ventricular epicardial surface of a young patient with Ebstein’s anomaly, facilitating effective
deﬁbrillation and anti-tachycardia pacing. The difﬁculties of conventional placement in Ebstein’s
malformation as well as the technique and outcome of epicardial lead implantation of a transvenous
deﬁbrillator-pacer system are discussed.
<Learning objective: This case report highlights the possible placement of a conventional transvenous
deﬁbrillator lead on alternative site such as epicardial surface as a solution in patients with Ebstein’s
anomaly undergoing open heart surgery. This case report also discusses technical challenges, which
precluded the transvenous implantation route in a post-operative patient with Ebstein’s anomaly. The
advantages of epicardial versus subcutaneous system are also discussed.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Sudden cardiac death is a recognized cause of late mortality in
patients with congenital heart disease despite successful correc-
tive surgery early in life. The role of implantable cardioverter-
deﬁbrillators (ICD) has become increasingly important as a
component of care in patients with congenital heart disease to
prevent sudden cardiac death [1]. However, implanting ICDs in
congenital heart patients may require creative solutions due to
various technical challenges [1–4]. In Ebstein’s malformation, the
morphological abnormalities limit the placement of endocardial
lead in the functional right ventricle. The difﬁculties of conven-
tional lead placement in Ebstein’s malformation and the effective-
ness of a transvenous ICD implanted on an alternative site such as
the epicardial surface is still not clear.
Case report
A 17-year-old (58 kg) college student presented following an
out-of-hospital cardiac arrest and successful resuscitation with an* Corresponding author at: Freeman Hospital, Newcastle Upon Tyne NE7 7DN,
UK. Tel.: +44 191 2137350; fax: +44 191 223 1152.
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tiredness and shortness of breath on minimal exercise. He was
taking no medications, including over the counter and recreational
drugs. On examination he was acyanotic with saturations of 95% in
room air. The ﬁrst and second heart sounds were accompanied by a
grade 2/6 systolic murmur at the left sternal edge. There were no
signs of cardiac failure. Electrocardiogram showed sinus rhythm
with right-axis deviation and wide QRS right bundle branch block.
The PR interval and QT interval were normal and there was no
obvious pre-excitation seen.
An echocardiogram was consistent with severe Ebstein’s
malformation; there was displacement of the septal leaﬂet of
the tricuspid valve by approximately 5 cm in the right ventricular
cavity. In addition, there was mild to moderate low-velocity
tricuspid regurgitation. There was no accompanying right ventric-
ular outﬂow obstruction. Left ventricular systolic function was
well preserved.
The patient was known to the adult congenital service, and had
been waiting for elective tricuspid valve repair and cavopulmonary
shunt prior to his cardiac arrest. Following his cardiac arrest, his
body temperature was cooled for 24 h and the patient was
subsequently extubated with intact neurology.
An electro-physiological (EP) study was performed, which ruled
out pre-excitation; however, monomorphic ventricular tachycar-
dia (VT) was easily inducible from programmed stimulation in the reserved.
Fig. 2.
Post-operative chest X-ray showed the position of the deﬁbrillator coil
lead on the left ventricular free wall as well as the pacing leads at the
apical position of the left ventricle.
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ventricular exit site, which was easily pace-terminated during
the EP study.
His presentation merited an ICD therapy as a prevention for
sudden cardiac death, but several issues were raised. Firstly, in
view of his need for a tricuspid valve repair in the future, a
conventional transvenous system which crossed the tricuspid
valve would be best avoided. Secondly, he may need a 1.5-ventricle
by creation of a bidirectional cavopulmonary anastomosis to
ofﬂoad the right ventricle (RV) after tricuspid valve repair, in which
case, a transvenous system would not be possible. A subcutaneous
ICD system would have been a viable alternative, but this would
have sacriﬁced the ability to treat any future VTs via anti-
tachycardia pacing, and it is worth recalling that the induced VT
during his EP study was readily pace-terminated.
We hypothesized that ﬁxing a transvenous lead on the
epicardial surface at the time of his surgery might offer the best
compromise. However, we were unsure whether the shock-coils of
the ICD lead implanted on the epicardial surface would be as
effective at deﬁbrillating the heart.
A review of the literature did not reveal any report of the
effectiveness of this approach, so we decided to attempt the
implant with on-table deﬁbrillation testing.
At surgery, the tricuspid valve was repaired using the cone
technique. The annulus and atrialized portion of the RV were
reduced taking care not to ensnare the coronary arteries. The atrial
septal defect was closed. The superior vena cava was divided and
joined to the right pulmonary artery to create a bidirectional
cavopulmonary shunt. A single-chamber Medtronic Protecta XT VR
(ICD-VVI; Medtronic, Minneapolis, MN, USA) deﬁbrillator-pacer unit
was implanted as follows: (i) the deﬁbrillator coil lead (Medtronic
Transvene1 6937 single SVC coil) was sutured on the epicardial
surface of the left ventricular free wall adjacent to the obtuse
marginal branch (Fig. 1). Therefore, the ICD coil lead lied in the
pericardial cavity posteriorly; (ii) the V pace/sense lead (Medtronic
CapSure Epi14968-bipolar 35 cm) was placed on the apical position
of the LV epicardial surface; (iii) a sub-pectoral pocket was then
created in the left infra-clavicular area and the leads were tunneled
under the pectoral muscles to connect to the deﬁbrillator-pacer unit.
The cardiopulmonary bypass was then weaned off uneventfully. The
deﬁbrillator was tested and functioned satisfactorily. Sensed R wave
was 22.5 mV, with a pacing threshold of 2.5 V at 0.5 ms. Epicardial
pacing lead impedance was measured at 949 Ohms and shock
impedance at 49 Ohms. Ventricular ﬁbrillation was induced usingFig. 1.
The deﬁbrillator coil lead was sutured on the epicardial surface of the
left ventricle free wall adjacent to the obtuse marginal branch.50 Hz frequency, and the device successfully deﬁbrillated the
rhythm back to sinus at 35 J, after a ﬁrst shock of 25 J failed to
terminate ventricular ﬁbrillation.
Post-operatively, his recovery and discharge were uneventful
(Fig. 2). The post-operative transthoracic echocardiography
demonstrated an excellent tricuspid valve repair. At one-month
follow-up, an ICD check showed an R-wave of 16 mV, ventricular
threshold of 0.75 V at 0.4 ms, ventricular pacing impedance of
893 Ohms, and shock impedance of 54 Ohms, and no events had
been detected or treated. He remained clinically well at follow-up
and echocardiography showed an excellent result from cone
reconstruction with a satisfactory ICD-pacemaker check at
approximately 18 months post-surgery.
Discussion
The implantation of an ICD on epicardial surface can be
considered when there is a venous access problem or in small
children, where conventional approaches would be difﬁcult [4]. This
case highlighted the challenges in implanting a deﬁbrillator unit in a
conventional way in Ebstein’s anomaly. In this malformation, the
true RV cavity is small due to atrialized portion. Additionally, the
septal and posterior leaﬂets are adherent to the RV endocardium.
These morphological abnormalities limit the placement of endocar-
dial lead in the functional RV. These limitations will not be overcome
by simply plicating the atrialized ventricle or reduction annulo-
plasty. The adherent leaﬂets have to be extensively mobilized as in
cone reconstruction technique to increase the functional RV area.
However, this involved extensive surgery on the tricuspid valve and
placement of a deﬁbrillator lead across the reconstructed valve is not
ideal. The placement of lead across this newly reconstructed valve
could also induce or aggravate tricuspid regurgitation, which would
be detrimental for RV function. Furthermore, the decision to create a
superior cavopulmonary shunt would preclude any transvenous
lead placement post-operatively.
The morphology of the VT suggested a left ventricular exit site,
highlighting the fact that ventricular architecture may be abnormal
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being considered as an ‘‘RV problem’’. The positioning of the shock-
coil lead was decided as a way of including a signiﬁcant part of the LV
in the shock vector; we chose this, as the clinical VT was originating
from the LV. In hindsight, perhaps other orientations and positions of
the shock-coil lead should have been attempted in an attempt to
optimize the deﬁbrillation threshold and aim for values under 25 J;
however, we were also keen to achieve a good pacing threshold as
we want the device to be able to retain its overdrive pacing function.
When the deﬁbrillation thresholds were discussed with the
electrophysiologist, it was felt that the device offered safety, even
though the lack of the 10 J safety margin in the threshold is a
compromise; furthermore, threshold may improve after chest
closure. In future, we would recommend that perhaps several
positions across both the left ventricle and RV should be tried to
ensure the best option.
As previously discussed, a subcutaneous ICD system would be an
alternative strategy, but this system does not allow the delivery of
anti-tachycardia pacing, meaning that all arrhythmias would be
treated with shocks as a ﬁrst-line therapy [1]. Furthermore,
discriminating a true VT from sinus tachycardia would have been
problematic in the presence of wide right-bundle branch morphol-
ogy in our patient’s resting electrocardiogram. Consequently,
exercise-induced sinus tachycardia may falsely trigger inappropri-
ate shocks in a young and active student.This case report highlights the possible placement of a
conventional transvenous deﬁbrillator lead on an alternative site
such as epicardial surface as an elegant solution to these speciﬁc
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